{"id":"NCT01559922","sponsor":"Suneva Medical, Inc.","briefTitle":"Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction","officialTitle":"A Phase 3 Randomized Placebo-Controlled Double-Blind Study of the Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-02","primaryCompletion":"2013-04","completion":"2014-02","firstPosted":"2012-03-21","resultsPosted":"2017-02-14","lastUpdate":"2019-11-01"},"enrollment":175,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Atrophic Acne Scar"],"interventions":[{"type":"DRUG","name":"Normal Saline","otherNames":[]},{"type":"DEVICE","name":"Artefill","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Artefill","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine whether Artefill is safe and effective for the correction of atrophic facial acne scars.","primaryOutcome":{"measure":"ASRS Responder Rate at 6 Months","timeFrame":"6 months post-treatment","effectByArm":[{"arm":"Placebo","deltaMin":32.4,"sd":null},{"arm":"Artefill","deltaMin":67.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":10,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":50},"commonTop":[]}}